Immunethep
PrivateLast Round
Grant
Apr 2, 2025
Total Funding Raised
$6.49M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Immunethep is a biotechnology company that develops preventive and therapeutic anti-bacterial immunotherapies targeting a shared virulence mechanism in pathogenic bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunethep Comparables
Compare Immunethep with similar companies based on industry and business-model similarity.
Immunethep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| Early Funding | Jul 31, 2024 | ||||
| Grant | Oct 18, 2022 | ||||
| Grant | Oct 23, 2017 | ||||
Seed | Apr 13, 2015 |
Key People
Founding team and executive leadership
Immunethep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Beta Capital | Early Funding |
| Portugal Ventures | Seed |
| IM Gestão de Ativos | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 1245% MoM, from 65 to 874.
- Jul 10, 2025
Monthly visitors grew 89% MoM, reaching 603.
Immunethep Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immunethep's valuation, stock price, and market status.
Is Immunethep a public or private company?
Immunethep is a private company.
What is the current stock price of Immunethep?
Immunethep is a private company with no public stock price. No recent secondary market data is available.
How much is Immunethep worth (valuation)?
Valuation information for Immunethep is not publicly available.
Can I buy Immunethep stock?
Immunethep shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immunethep's last funding round?
Immunethep's most recent funding round was Grant on April 2, 2025.
Who are the main investors in Immunethep?
Key investors in Immunethep include Beta Capital, Portugal Ventures.
Will Immunethep IPO soon?
No public IPO plans have been announced for Immunethep.
How can I track Immunethep secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immunethep's secondary market activity and sign up for updates.